promotion image of download ymail app
Promoted
Anonymous
Anonymous asked in Politics & GovernmentPolitics · 2 months ago

Isn't it sad that this patient's last words were, "Who's going to pay for it" before being intubated? Why is US healthcare such a mess?

4 Answers

Relevance
  • ?
    Lv 7
    2 months ago
    Favorite Answer

    It is sad, very sad. US healthcare is such a mess due an accumulation and nexus of various factors. Obmacare was the first good fix we had in many decades and Trump and his Republicans subsequently chipped away at it.....to be replaced with NOTHING but more of the same mess. 

    • Commenter avatarLogin to reply the answers
  • 2 months ago

    If anything good comes out of coronavirus, it will be an expansion of Obamacare into something like Medicare for all, and major investments in our hospitals, especially in rural areas where for-profit hospitals simply cannot survive.

    • Commenter avatarLogin to reply the answers
  • Jeff D
    Lv 7
    2 months ago

    What's sad is that the story didn't bother to mention that the recently passed CARES Act allocates $100 billion in emergency funds for hospitals and health care providers to reimburse providers treating uninsured COVID-19 patients.

    But never let a serious crisis go to waste.

    • Commenter avatarLogin to reply the answers
  • Anonymous
    2 months ago

    Very sad.

    There are many reasons why the United States, which spends the most per capita on health care each year of any wealthy nation, is lagging behind other countries in health care access. Compared to other wealthy nations, the United States stands out for lacking a universal health care system and for prioritizing corporate profits over health. This has led to a fragmented health care system that is ill-equipped for a coordinated response in a time of crisis, such as the current pandemic.

    Health insurance companies pushed back when President Trump announced treatment for COVID-19 would be covered without requiring co-pays. America’s Health Insurance Plans, an industry lobbying group, immediately clarified this would only apply to testing, not to treatment. Rising Pharmaceuticals, which manufactures the antimalarial drug Chloroquine that is being tested for use against COVID-19, raised the price of the drug by nearly 100 percent in late January.

    We will see many bankruptcies and much higher insurance rates.

    • Commenter avatarLogin to reply the answers
Still have questions? Get your answers by asking now.